Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT02643836
Other study ID # 2014D006902
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date September 1, 2016
Est. completion date September 1, 2016

Study information

Verified date May 2018
Source Spaulding Rehabilitation Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objectives are to evaluate impact of Pulsed electromagnetic field (PEMF) therapy on patients with Post-Concussive Syndrome with Rivermead Post Concussion Symptom Questionnaire (RPQ) as a primary outcome, followed by fatigue and mood as second and tertiary outcomes respectively. The investigators will also investigate brain tissue activity and oxygenation by evaluating brain wave activity via non-invasive quantitative electroencephalogram and near infrared spectroscopy testing pre and post study to better understand the metabolic effect of the PEMF intervention.

The investigators hypothesize that the PEMF treatment will have an effect on improvement of brain metabolism as measured by Near Infrared Spectroscopy which will in turn assist with improvement of the chronic symptoms of cognitive deficits, mood and fatigue as related to Post-Concussive Syndrome.


Description:

76 subjects will be enrolled for this experiment. Each subject will go through the screening procedure as outlined above. After consent and screening are complete each subject will receive a hat that delivers three 15 minute stimulations per day for the duration of 6 weeks. Each study subject will receive two hats, which contain the integrated PEMF device, this will be done to ensure continuity of treatment in case that one of the hats stops working due to the battery running out.

The PEMF device to be used will be an investigational, battery powered custom-made stimulator able to deliver an electromagnetic field. This device operates at very low amplitude (0.05 gauss magnetic field strength) and requires only watch batteries for power, which allows the technology to be portable (e.g., used at home), versatile, inexpensive, and safe, (vi) we have integrated the PEMF device into a wearable baseball hat to improve tolerance and compliance and can also monitor patient use in this configuration.

The study device consists of a printed circuit board PEMF signal generator and an AAA battery-driven power supply encased in high density plastic, a solid wire-loop antenna covered in medical grade silicone, all of which are built into a standard baseball-style cap, with the antenna fitted around its largest internal circumference. The device was designed to be easily used and is activated by donning the cap. Once donned, a 15-minute treatment cycle starts and stops automatically. The device requires at least 2 hours between treatments, and cannot be activated again until that period has elapsed. A light on the power supply blinks while the unit is active. EEG and NIR will be obtained at visits 1, 2 and at three month follow up to better evaluate brain oxygenation and metabolism.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date September 1, 2016
Est. primary completion date September 1, 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years to 30 Years
Eligibility Inclusion Criteria:

- History of a mild or moderate traumatic brain injury in the previous 6 months related to a sports injury

- Symptomatic Rivermead Postconcussion Symptom Questionnaire (RPQ) scores (RPQ 3 > 3, RPQ 13 >8)

- Age 18-30

- Willing and able to sign informed consent

- Willing and able to attend all study assessments

Exclusion Criteria:

- Severe traumatic brain injury defined by a post-injury Glasgow Coma Scale score = 8 greater than 30 minutes following the injury or post-traumatic amnesia lasting longer than 1 week

- Time since injury less than 4 weeks or greater than 6 months

- Any concussion that is not sustained during sports activity

- Concussions sustained during mixed martial arts or boxing activities

- Positive CT scan or MRI related to brain injury

- Recently beginning methylphenidate or amphetamine-dextroamphetamine treatment within two months

- Pre-existing diagnosis of learning disability or neurodevelopmental disorder (other than ADD/ADHD)

- Pre-existing significant neurological disorder (e.g., seizures, CNS neoplasms) or history of neurosurgical intervention

- Prior psychiatric hospitalization

- Current substance abuse or dependence (AUDIT-C)

- Pacemaker

- Implanted stimulation devices

- Pregnant

- Unstable medical conditions

- Unable to read and/or understand the purpose and participating conditions of the study

- Any condition that would prevent participation in study procedures or condition the investigator believes would make the subject unsuitable for participation in the study.

- Non-English speaking

Study Design


Intervention

Device:
PEMF
The PEMF device (Rio Grande Neurosciences - RGN) the investigators would be testing has been shown to have significant anti-inflammatory effects in animals and humans and an excellent safety profile in several clinical studies. Key findings demonstrated that PEMF-treated rodents with a closed-head TBI exhibited a 5-fold decrease in IL-1b in the cerebral spinal fluid, an outcome associated with decreased neuropathology and improved function.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Spaulding Rehabilitation Hospital Rio Grande Neurosciences

References & Publications (1)

Boake C, McCauley SR, Levin HS, Pedroza C, Contant CF, Song JX, Brown SA, Goodman H, Brundage SI, Diaz-Marchan PJ. Diagnostic criteria for postconcussional syndrome after mild to moderate traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2005 Summe — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Rivermead Post-Concussion Symptom Questionnaire basic post-concussion questionaire 5 minutes
Secondary Ruff Neurobehavioral Inventory basic neurobehavioral inventory 6 minutes
See also
  Status Clinical Trial Phase
Completed NCT03304327 - Mindfulness and Yoga Training for Athletes With Concussion (MYTAC) N/A
Completed NCT05562544 - EEG Diagnostic for Repetitive Sub-concussive Head Impacts
Terminated NCT02988609 - Concussion in Rugby Players: a Pilot Study of Neural Recovery Using fMRI N/A
Completed NCT02710123 - Sub-Threshold Exercise Treatment for Adolescents With Sports Related Concussion N/A
Terminated NCT02100150 - A Safety and Efficacy Study of NNZ-2566 in Patients With Mild Traumatic Brain Injury (mTBI) Phase 2
Active, not recruiting NCT01874847 - PLAY GAME: Post-concussion Syndrome in Youth - Assessing the GABAergic Effects of Melatonin Phase 2/Phase 3
Completed NCT01903525 - DHA For The Treatment of Pediatric Concussion Related to Sports Injury Phase 1
Completed NCT02262507 - Concussion Device Audiological Measures N/A
Enrolling by invitation NCT05948501 - The Effects of Concussion on Gait and Posture in Individuals With Peripheral Vision Loss
Recruiting NCT03360786 - Primary Prevention of Concussion in Youth Ice Hockey Players N/A
Recruiting NCT03710109 - Evaluation of an EEG Based Concussion System
Not yet recruiting NCT02930395 - Blood Biomarkers for the Management of Concussion in Professional Rugby Players N/A
Completed NCT02271451 - Q-collar and Brain Injury Biomarkers N/A
Completed NCT02268240 - Care for Post-Concussive Symptoms N/A
Completed NCT02278029 - Driving Performance of Teenage Patients With mTBI: a Longitudinal Assessment N/A
Completed NCT02268058 - Use of Ibuprofen and Acetaminophen for Treatment of Acute Headache Post Concussion in Children N/A
Active, not recruiting NCT03608722 - Video Games to Track Cognitive Health N/A
Completed NCT02556177 - Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2 N/A
Completed NCT02660164 - A Study to Assess the Effectiveness of the Nautilus BrainPulseâ„¢ as an Aid in the Diagnosis of Concussion
Completed NCT02344446 - Physical Therapy Intervention for Extended Physical Symptoms After a Sports-related Concussion N/A